Bill Starling is a co-founder of Synergy Life Science Partners. Additionally, Bill is Chief Executive Officer of Synecor, LLC, a business generator and financial incubator of new medical device companies. During his tenure with Synecor, Bill has co-founded and invested in five major medical device companies, including Synecor.

Bill began his career in the medical technology device industry at American Edwards Laboratories (Edwards LifeSciences). He was subsequently part of the founding management team and Director of marketing for Advanced Cardiovascular Systems, Inc. (acquired by Guidant/Abbott) and was a cofounder, Vice President and Board Member of Ventritex, inc. (acquired by St. Jude medical). In 1992, Bill was a cofounder, Chairman of the Board of Directors and President/CEO of Cardiac Pathways Corporation (acquired by Boston Scientific Corporation) and was responsible for raising significant capital from the early venture capital period through an initial public offering in 1996.

Bill is a co-founder of BaroSense, InnerPulse and TransEnterix and is the Chairman of the Board at iRhythm Technologies.

Bill serves as Chairman of the Board of Visitors at the Kenan-Flagler Business School at the University of North Carolina at Chapel Hill and the External Advisory Board of the Stanford Stroke Center at the Stanford University Medical Center. Bill received his B.S. from the University of North Carolina at Chapel Hill and his M.B.A. degree from the University of Southern California.